Clinical Trial Update: Frontline Immunotherapy Combined With Radiation and Chemotherapy in High Risk Endometrial Cancer [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating frontline immunotherapy combined with radiation and chemotherapy in high-risk endometrial cancer is active but not recruiting.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: University of Oklahoma | Conditions: Endometrial Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING